Literature DB >> 15761242

Acromegaly and cancer.

Paul J Jenkins1.   

Abstract

In recent years, it has become increasingly recognized that acromegaly is associated with an increased prevalence of colorectal cancer and pre-malignant tubular adenomas. The aetiology of these tumours is unknown but is likely to reflect increased levels of both insulin-like growth factor I (IGF-I), which is implicated in the development of sporadic colorectal cancer, and environmental factors, such as the bile acid deoxycholic acid. There is also evidence to suggest that the prevalence of breast and perhaps haematological malignancies might be increased in acromegaly, although these associations have been based on mostly small epidemiological surveys and clarification will come in the future once large-scale epidemiological studies have been completed. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15761242     DOI: 10.1159/000080768

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  25 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

2.  Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver.

Authors:  Ma Eugenia Díaz; Lorena González; Johanna G Miquet; Carolina S Martínez; Ana I Sotelo; Andrzej Bartke; Daniel Turyn
Journal:  Cell Signal       Date:  2011-10-14       Impact factor: 4.315

Review 3.  Protective effects of short-term dietary restriction in surgical stress and chemotherapy.

Authors:  Sebastian Brandhorst; Eylul Harputlugil; James R Mitchell; Valter D Longo
Journal:  Ageing Res Rev       Date:  2017-02-20       Impact factor: 10.895

Review 4.  The biological actions of dehydroepiandrosterone involves multiple receptors.

Authors:  Stephanie J Webb; Thomas E Geoghegan; Russell A Prough; Kristy K Michael Miller
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

5.  Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.

Authors:  Karen J Wernli; Polly A Newcomb; Yinghui Wang; Karen W Makar; Mazyar Shadman; Victoria M Chia; Andrea Burnett-Hartman; Michelle A Wurscher; Yingye Zheng; Margaret T Mandelson
Journal:  Growth Horm IGF Res       Date:  2010-05-26       Impact factor: 2.372

6.  Adrenal morpho-functional alterations in patients with acromegaly.

Authors:  C Scaroni; R Selice; S Benedini; E De Menis; M Arosio; C Ronchi; M Gasperi; L Manetti; G Arnaldi; B Polenta; M Boscaro; N Albiger; E Martino; F Mantero
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

Review 7.  Current diagnosis of acromegaly.

Authors:  Rocio A Cordero; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 8.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

Review 9.  Metabolic syndrome and risk of subsequent colorectal cancer.

Authors:  Raluca Pais; Horatiu Silaghi; Alina-Cristina Silaghi; Mihai-Lucian Rusu; Dan-Lucian Dumitrascu
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.